Popular Articles
Natural Remedies

Recent Studies And Surveys
New England Journal of Medicine: Medicare Part D Update - Lessons Learned And Unfinished Business - "Since 2006, more than 40 million elderly and disabled people have had the opportunity to enroll in a Medicare Part D prescription-drug plan, as established under the Medicare Modernization Act (MMA) of 2003." At that time, lawmakers focused on several features of the proposed legislation. "Issues that received particular scrutiny were the unprecedented way that the benefit would be delivered (exclusively through private plans) and its design, featuring an unusual gap in coverage (sometimes called the "doughnut hole")." Four years into the program, "the Obama administration and the Democratically controlled Congress have an opportunity to review the program and identify areas for improvement." This study, The Medicare Policy Project of the Henry J. Kaiser Family Foundation, returns to some of the key questions raised during the congressional debate and in the years that led up to the program"s start (Neuman and Cubanski, July 23). (Note: KHN is a program of the Kaiser Family Foundation.)
generic viagra online
Government Of Canada Approves A New Of Medical Isotopes
The Honourable Leona Aglukkaq, Minister of Health, announced the approval of a new of the medical isotope Iodine-131 (I-131) to treat thyroid cancer in Canada.
News of the day
What Are Gallstones? What Causes Gallstones?
Gallstones are lumps or stones that develop in the gallbladder or bile duct. Some of the chemicals which exist in the gallbladder, such as cholesterol, calcium bilirubinate, and calcium carbonate, harden into either one large stone or many small ones. According to Medilexicon"s medical dictionary, a gallstone is "A concretion in the gallbladder or a bile duct, composed chiefly of a mixture of cholesterol, calcium bilirubinate, and calcium carbonate, occasionally as a pure stone composed of just one of these substances". An article describes a gallbladder in the bile duct similar to trying to squeeze a golf ball through a straw.
Cardiovascular

New Clinical Study On Type 2 Diabetes Begins Enrollment At New York Hospital Queens

Diabetes affects nearly 24 million people in the United States. The most widespread form is type 2 diabetes, accounting for about 90 to 95 percent of all diagnosed cases of diabetes, according to the American Diabetes Association (ADA). The research team at New York Hospital Queens is offering the community a chance to participate in a new type 2 diabetes study. The study, called TINSAL-T2D (Targeting Inflammation using Salsalate in Type 2 Diabetes), looks at the safety and effectiveness of an investigational medication (similar to aspirin) in the treatment of type 2 diabetes. The study medication has been approved by the U.S. Food and Drug Administration to treat arthritis, but it has not yet been approved for diabetes. To be eligible for this study, participants must have type 2 diabetes, be between 18 and 75 years old, and be on a stable dose of oral anti-diabetic medication and the diabetes is still not well controlled. The study includes 12 visits to the Lang Research Center over approximately one year. Qualified participants will receive a physical exam and laboratory tests at no cost. Participants will be compensated for their time and effort. Nationally lauded endocrinologist, Daniel Lorber, M.D., associate director, Eugene and Theresa Lang Research Center for Research and Education at New York Hospital Queens, is the principal investigator of the clinical trial. Last month, Dr. Lorber received the ADA"s "Outstanding Physician Clinician Award" for his contributions to the ongoing fight against diabetes. A clinical trial is a scientific study that evaluates the safety and effectiveness of medical treatments, drugs or devices. These studies are required by the U.S. Food and Drug Administration for manufacturers to earn approval for new products and new uses for existing products. New York Hospital Queens is a member of the NewYork-Presbyterian Healthcare System and is an affiliate of the Weill Medical College of Cornell University. American Diabetes Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):